Atlas Trials

A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).

Clinical trial NCT00978536 · TERMINATED

Trial details

NCT number
NCT00978536
Sponsor
Nantes University Hospital
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Disseminated Sclerosis
Start date
2009-02-01
Primary completion
2011-11-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.